As for the human breast cancer cells (SUM225) in which endogenous ERLIN2 is overexpressed, the cancer cells likely utilize ERLIN2 to remodel the microtubule structure and cell division cycle, which help the cancer cells gain growth advantage and drug resistance. This evidence concerns the gene ERLIN2 and cancer.